Literature DB >> 24175157

Reading a cost-effectiveness or decision analysis study: Five things to consider.

Kate C Young1, Adam G Kelly, Robert G Holloway.   

Abstract

Cost-effectiveness studies and decision analyses of neurologic practices, treatments, and technologies are increasing in the literature and have an emerging role within both medicine and neurology. Knowledge about these research approaches, how to interpret the results of such studies, as well as an understanding of their limitations will be of growing importance for the practicing neurologist. We discuss 5 aspects of these analyses to increase awareness about the uses and limitations of cost-effectiveness articles in everyday practice.

Year:  2013        PMID: 24175157      PMCID: PMC3806934          DOI: 10.1212/CPJ.0b013e3182a78fd8

Source DB:  PubMed          Journal:  Neurol Clin Pract        ISSN: 2163-0402


  21 in total

1.  Quantification of the potential impact of cost-effectiveness thresholds on dutch drug expenditures using retrospective analysis.

Authors:  Cornelis Boersma; Adriaan Broere; Maarten J Postma
Journal:  Value Health       Date:  2010 Sep-Oct       Impact factor: 5.725

2.  Is hospitalization after TIA cost-effective on the basis of treatment with tPA?

Authors:  Mai N Nguyen-Huynh; S Claiborne Johnston
Journal:  Neurology       Date:  2005-12-13       Impact factor: 9.910

3.  Evidence-based decision-making within Australia's pharmaceutical benefits scheme.

Authors:  Ruth Lopert
Journal:  Issue Brief (Commonw Fund)       Date:  2009-07

4.  Comparison of a generic to disease-targeted health-related quality-of-life measures for multiple sclerosis.

Authors:  B G Vickrey; R D Hays; B J Genovese; L W Myers; G W Ellison
Journal:  J Clin Epidemiol       Date:  1997-05       Impact factor: 6.437

5.  Why the ethics of parsimonious medicine is not the ethics of rationing.

Authors:  Jon C Tilburt; Christine K Cassel
Journal:  JAMA       Date:  2013-02-27       Impact factor: 56.272

6.  Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

Authors:  Oscar R Benavente; Robert G Hart; Leslie A McClure; Jeffrey M Szychowski; Christopher S Coffey; Lesly A Pearce
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

7.  Getting to value in neurological care: a roadmap for academic neurology.

Authors:  Robert G Holloway; Steven P Ringel
Journal:  Ann Neurol       Date:  2011-06       Impact factor: 10.422

8.  Should TIA patients be hospitalized or referred to a same-day clinic?: a decision analysis.

Authors:  Jay K Joshi; Bichun Ouyang; Shyam Prabhakaran
Journal:  Neurology       Date:  2011-11-16       Impact factor: 9.910

9.  Health state preferences and decision-making after malignant middle cerebral artery infarctions.

Authors:  Adam G Kelly; Robert G Holloway
Journal:  Neurology       Date:  2010-07-14       Impact factor: 9.910

10.  Health economic assessment: cost-effectiveness thresholds and other decision criteria.

Authors:  Steven Simoens
Journal:  Int J Environ Res Public Health       Date:  2010-04-20       Impact factor: 3.390

View more
  4 in total

1.  Cost-effectiveness analyses: Beauty and the beast?

Authors:  Gary R Cutter; Guoqiao Wang
Journal:  Neurol Clin Pract       Date:  2013-10

2.  Cost-effectiveness data: Are neurologists in practice equipped to interpret them?

Authors:  Saty Satya-Murti
Journal:  Neurol Clin Pract       Date:  2013-10

3.  Economic study of the value of expanding HCV treatment capacity in Germany.

Authors:  Urbano Sbarigia; Daniel Wirth; Karen Van Nuys; Caroline Huber; Ron Brookmeyer; Jona Stahmeyer; Christian Krauth
Journal:  BMJ Open Gastroenterol       Date:  2017-04-04

4.  The cost-utility of CT angiography and conventional angiography for people presenting with intracerebral hemorrhage.

Authors:  Richard I Aviv; Adam G Kelly; Babak S Jahromi; Curtis G Benesch; Kate C Young
Journal:  PLoS One       Date:  2014-05-13       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.